Memantine in Adult Autism Spectrum Disorder
Status: Terminated
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• Participant is currently in treatment in the Johns Hopkins Bayview Medical Center (JHBMC)
• Participant has a diagnosis of:
‣ Autistic Disorder
⁃ Asperger's Disorder
⁃ Pervasive Developmental Disorder (PDD) NOS
• Participant meets one of the following criteria:
‣ CGI-S \>= 4 (CGI-S: \_\_\_\_\_\_\_\_)
⁃ Participant has the following problematic behaviors (at least one) that might be expected to benefit from memantine:
∙ \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Locations
United States
Maryland
Johns Hopkins Bayview
Baltimore
Time Frame
Start Date: 2010-02
Completion Date: 2010-07
Participants
Target number of participants: 4
Treatments
Placebo_comparator: Placebo
Treatment as usual plus placebo
Active_comparator: memantine
Treatment as usual plus memantine
Related Therapeutic Areas
Sponsors
Collaborators: Forest Laboratories
Leads: Johns Hopkins University